Linarin Shows Promise in Treating Asthma with Novel Therapeutic Mechanism

Strategic Insights -

A recent study published in Phytomedicine has discovered a novel therapeutic mechanism for treating asthma using linarin, a flavone glycoside. Researchers from Yanbian University in China investigated the effects of linarin on asthma and identified its molecular mechanism, which involves the interaction with aldehyde dehydrogenase 2 (ALDH2). The study found that linarin directly binds to and stabilizes ALDH2, triggering a novel ALDH2/MAOA axis that inhibits excessive mitochondrial fission, oxidative stress, and inflammation, thereby maintaining mitochondrial homeostasis and preventing epithelial cell ferroptosis.

Key Takeaways:

  • Linarin, a flavone glycoside, has been shown to have therapeutic effects on asthma by modulating the ALDH2/MAOA axis.
  • The study employed a house dust mite (HDM)-induced murine asthma model, multi-omics bioinformatic analysis, and in vitro molecular validation experiments to assess the effects of linarin.
  • Linarin directly binds to and stabilizes ALDH2, which triggers a novel signaling cascade that inhibits mitochondrial dysfunction, inflammation, and ferroptosis.
  • The preservation of mitochondrial integrity suppresses the activation of the cGAS-STING inflammatory pathway, and restores key regulatory proteins like GPX4.
  • The study provides a solid theoretical foundation for developing linarin as a precision-targeted therapeutic drug for asthma.

Statistics:

  • The study used a house dust mite (HDM)-induced murine asthma model to evaluate linarin's in vivo efficacy.
  • Multi-omics and machine learning approaches were employed to identify linarin's molecular target, and a suite of in vitro molecular assays were conducted to validate the target and dissect the signaling cascade.
  • Linarin was found to directly bind to and stabilize ALDH2.

Sources:

  • Linarin protects against asthma-induced airway epithelial ferroptosis and inflammation via ALDH2 regulation. Phytomedicine, 2025;148:157398.
  • Phytomedicine can be contacted at: Elsevier Gmbh, Hackerbrucke 6, 80335 Munich, Germany.
  • The news correspondents report that additional information may be obtained from Qiaoyun Bai, Dept. of Anatomy Histology and Embryology, Yanbian University, Yanji 133002, People's Republic of China.